The article identifies issues such as poor socioeconomic background and lack of family and social support as factors in poor medication adherence, which today are recognized as social determinants of health
Welcome to Paper of the Week, which looks back at research and commentary from the past 25 years in The American Journal of Managed Care®, and why they matter today.
This week’s paper, “Medication Noncompliance in Patients With Chronic Disease: Issues in Dialysis and Renal Transplantation,” examines the problems with patients who must undergo a kidney transplant but still don’t stick with basic medication regimens for conditions like hypertension, which add to their medical challenges.
The article identifies issues such as poor socioeconomic background and lack of family and social support as factors in poor medication adherence, which today are recognized as social determinants of health.
This week, CMS offered a proposal for helping patients with end-stage renal disease enroll in Medicare Advantage, which complement payment models for renal treatment called Kidney Care First. Overall, the current initiatives in CMS are designed to make nephrologists, dialysis centers, and others involved in renal care more accountable for patients’ overall health.
For the Paper of the Week, visit ajmc.com.
For more about Kidney Care First, see ajmc.com.
Managed Care Reflections: A Q&A With Jan E. Berger, MD, MJ
January 7th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The January issue features a conversation with longtime editorial board member Jan E. Berger, MD, MJ, the CEO of Health Intelligence Partners.
Read More
Transforming Kidney Care: Policy, Risk Stratification, and Collaborative Models
December 12th 2024Experts at a recent Institute for Value-Based Medicine event emphasized the importance of early intervention, policy innovation, and proactive collaboration to transform the management of kidney disease and optimize patient outcomes.
Read More
Long-Term Benefits Show the Value of Upfront Investments in Value-Based Care
October 17th 2024Miriam Godwin, CMMI, National Kidney Foundation, touches on the gaps in kidney care that public policy can address, as well as the importance of thinking about the long-term benefits of value-based care.
Read More